1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Easywell Biomedicals, Inc.

Easywell Biomedicals, Inc.

1799.TWO
Easywell Biomedicals, Inc.TW flagTaipei Exchange
33.90
TWD
+0.40
- -
4.23BMarket Cap

Total Valuation

Easywell Biomedicals, Inc. carries a market capitalization of 4.23B, placing it among publicly traded companies globally. Its enterprise value stands at 4.37B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap4.23B
Enterprise Value4.37B

Share Statistics

Easywell Biomedicals, Inc. currently has 124.69M shares outstanding.

Shares Outstanding124.69M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 7.34, and the price-to-book ratio stands at 9.02.

PE RatioN/A
PS Ratio7.34
PB Ratio9.02
P/TBV Ratio7.29
P/FCF Ratio31.28
P/OCF Ratio35.15

Enterprise Valuation

EV / Sales7.32
EV / EBITDAN/A
EV / EBITN/A
EV / FCF26.86

Financial Position

Easywell Biomedicals, Inc. maintains a current ratio of 2.52, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 60.62, indicating elevated leverage, while an interest coverage ratio of -3.11 demonstrates limited ability to service its debt obligations.

Current Ratio2.52
Quick Ratio1.62
Debt / Equity60.62
Debt / EBITDA-6.10
Interest Coverage-3.11

Financial Efficiency

Return on Equity (ROE)-13.94
Return on Assets (ROA)-5.23
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.52

Taxes

Income Tax304,000.00
Effective Tax RateN/A

Stock Price Statistics

Easywell Biomedicals, Inc.'s stock has declined approximately -31.4459% over the past 52 weeks. The 50-day moving average sits at 34.10, while the 200-day moving average is 36.21.

Beta (5Y)N/A
52-Week Price Change-31.4459%
50-Day Moving Average34.10
200-Day Moving Average36.21
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Easywell Biomedicals, Inc. generated 597.41M in revenue and converted that into -73.14M in net income, yielding earnings per share of -0.62. EBITDA reached -69.85M, while operating income came in at -69.85M.

Revenue597.41M
Gross Profit280.31M
Operating Income-69.85M
Pretax Income-75.18M
Net Income-73.14M
EBITDA-69.85M
EBIT-69.85M
Earnings Per Share (EPS)-0.62

Balance Sheet

Easywell Biomedicals, Inc. holds 451.69M in cash and equivalents against 425.91M in total debt, resulting in a net debt position of -191.14M. Total book value stands at 485.97M, with working capital of 421.78M providing operational flexibility.

Cash & Cash Equivalents451.69M
Total Debt425.91M
Net Debt-191.14M
Equity (Book Value)485.97M
Book Value Per Share3.97
Working Capital421.78M

Cash Flow

Easywell Biomedicals, Inc. produced 124.78M in operating cash flow over the past twelve months. After subtracting -15.41M in capital expenditures, free cash flow totaled 109.37M - equivalent to 0.89 per share.

Operating Cash Flow124.78M
Capital Expenditures-15.41M
Free Cash Flow109.37M
FCF Per Share0.89

Margins

Easywell Biomedicals, Inc. operates with a gross margin of 46.92, reflecting its pricing power and cost economics. The operating margin of -11.69 and net profit margin of -12.24 provide insight into operational efficiency.

Gross Margin46.92
Operating Margin-11.69
Pretax Margin-12.58
Profit Margin-12.24
EBITDA Margin-11.69

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield3.25
FCF Yield3.20

Stock Splits

Easywell Biomedicals, Inc.'s most recent stock split took place on September 30, 2022 with a 10:7 split ratio.

Last Split Date9/30/2022
Split Ratio10:7

Scores

Easywell Biomedicals, Inc. posts an Altman Z-Score of 4.30, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.30